Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histones | 20 | 2024 | 361 | 4.340 |
Why?
|
| RNA, Long Noncoding | 3 | 2023 | 129 | 1.620 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2021 | 139 | 1.310 |
Why?
|
| Protein Processing, Post-Translational | 11 | 2024 | 411 | 1.290 |
Why?
|
| Nucleosomes | 7 | 2024 | 61 | 1.260 |
Why?
|
| Lysine | 5 | 2017 | 182 | 1.240 |
Why?
|
| Chromatin | 9 | 2024 | 440 | 1.210 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 4 | 2021 | 77 | 0.880 |
Why?
|
| Antigens, Nuclear | 2 | 2017 | 28 | 0.880 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2023 | 537 | 0.790 |
Why?
|
| Antibodies | 4 | 2024 | 348 | 0.730 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 502 | 0.710 |
Why?
|
| Methylation | 9 | 2024 | 288 | 0.700 |
Why?
|
| Leukemia | 2 | 2021 | 301 | 0.660 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2021 | 132 | 0.660 |
Why?
|
| Gene Rearrangement | 1 | 2021 | 168 | 0.650 |
Why?
|
| Bayes Theorem | 1 | 2021 | 402 | 0.600 |
Why?
|
| Cell Nucleus | 3 | 2020 | 603 | 0.590 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 1117 | 0.570 |
Why?
|
| Heterochromatin | 1 | 2018 | 26 | 0.570 |
Why?
|
| Sequence Analysis, DNA | 2 | 2019 | 893 | 0.570 |
Why?
|
| Chromosome Mapping | 1 | 2021 | 1052 | 0.550 |
Why?
|
| PHD Zinc Fingers | 1 | 2017 | 1 | 0.540 |
Why?
|
| Transcription Factors | 4 | 2017 | 1691 | 0.520 |
Why?
|
| Histone Code | 3 | 2018 | 19 | 0.500 |
Why?
|
| Open Reading Frames | 1 | 2015 | 113 | 0.450 |
Why?
|
| Homeodomain Proteins | 5 | 2024 | 556 | 0.390 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1985 | 0.370 |
Why?
|
| Calorimetry | 1 | 2012 | 15 | 0.360 |
Why?
|
| Protein Binding | 7 | 2024 | 1534 | 0.350 |
Why?
|
| Gene Library | 2 | 2023 | 126 | 0.350 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 78 | 0.350 |
Why?
|
| Antibody Specificity | 3 | 2019 | 126 | 0.320 |
Why?
|
| Sequence Analysis, RNA | 2 | 2023 | 255 | 0.320 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 555 | 0.310 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 2 | 2006 | 11 | 0.310 |
Why?
|
| Peptide Fragments | 1 | 2012 | 470 | 0.310 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2715 | 0.310 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2021 | 166 | 0.290 |
Why?
|
| Amino Acid Sequence | 4 | 2017 | 2012 | 0.280 |
Why?
|
| Calibration | 2 | 2019 | 106 | 0.260 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2007 | 79 | 0.260 |
Why?
|
| Humans | 27 | 2024 | 93515 | 0.260 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 1234 | 0.260 |
Why?
|
| DNA | 3 | 2021 | 1265 | 0.250 |
Why?
|
| DNA Gyrase | 1 | 2005 | 2 | 0.230 |
Why?
|
| DNA, Superhelical | 1 | 2005 | 15 | 0.230 |
Why?
|
| Histone Acetyltransferases | 2 | 2024 | 45 | 0.220 |
Why?
|
| Cell Line | 5 | 2017 | 2464 | 0.220 |
Why?
|
| Models, Molecular | 7 | 2024 | 1353 | 0.220 |
Why?
|
| Animals | 15 | 2024 | 28155 | 0.220 |
Why?
|
| Genome | 2 | 2019 | 407 | 0.210 |
Why?
|
| Thermodynamics | 2 | 2017 | 325 | 0.210 |
Why?
|
| Escherichia coli | 2 | 2013 | 563 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2024 | 298 | 0.190 |
Why?
|
| HEK293 Cells | 2 | 2015 | 696 | 0.190 |
Why?
|
| DNA, Complementary | 1 | 2023 | 384 | 0.190 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 630 | 0.190 |
Why?
|
| Protein Isoforms | 1 | 2023 | 295 | 0.190 |
Why?
|
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2021 | 20 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 1 | 2021 | 44 | 0.170 |
Why?
|
| RNA Splicing | 1 | 2022 | 157 | 0.170 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 2910 | 0.170 |
Why?
|
| Alternative Splicing | 1 | 2022 | 219 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 5 | 2011 | 729 | 0.170 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2021 | 99 | 0.170 |
Why?
|
| Datasets as Topic | 1 | 2021 | 81 | 0.170 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2021 | 129 | 0.170 |
Why?
|
| Sequence Alignment | 1 | 2021 | 352 | 0.160 |
Why?
|
| Crystallography, X-Ray | 5 | 2016 | 520 | 0.160 |
Why?
|
| Computational Biology | 2 | 2020 | 578 | 0.150 |
Why?
|
| Oncogenes | 1 | 2019 | 100 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 295 | 0.150 |
Why?
|
| Binding Sites, Antibody | 2 | 2016 | 47 | 0.140 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2018 | 32 | 0.140 |
Why?
|
| Daunorubicin | 1 | 2018 | 77 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 33 | 0.140 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2018 | 87 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 641 | 0.140 |
Why?
|
| Transcriptome | 1 | 2023 | 762 | 0.140 |
Why?
|
| Acetylation | 2 | 2024 | 149 | 0.130 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 67 | 0.130 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 245 | 0.130 |
Why?
|
| Oligopeptides | 1 | 2018 | 191 | 0.130 |
Why?
|
| Xenopus | 2 | 2020 | 119 | 0.120 |
Why?
|
| HeLa Cells | 2 | 2015 | 517 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2026 | 0.120 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 127 | 0.120 |
Why?
|
| Protein Conformation | 4 | 2007 | 914 | 0.120 |
Why?
|
| Binding Sites | 4 | 2024 | 1133 | 0.120 |
Why?
|
| Genome, Human | 1 | 2021 | 823 | 0.120 |
Why?
|
| RNA | 1 | 2020 | 573 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2020 | 697 | 0.120 |
Why?
|
| Peptides | 2 | 2011 | 656 | 0.110 |
Why?
|
| Protein Array Analysis | 1 | 2015 | 53 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 962 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 317 | 0.110 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2016 | 86 | 0.110 |
Why?
|
| Antigens | 1 | 2016 | 224 | 0.110 |
Why?
|
| Reference Standards | 1 | 2015 | 146 | 0.110 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2015 | 98 | 0.110 |
Why?
|
| Mice | 6 | 2024 | 12269 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 636 | 0.110 |
Why?
|
| Databases, Genetic | 1 | 2015 | 282 | 0.100 |
Why?
|
| Antibody Affinity | 1 | 2013 | 38 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2018 | 392 | 0.100 |
Why?
|
| Proteins | 1 | 2018 | 803 | 0.100 |
Why?
|
| Phenyl Ethers | 1 | 2012 | 13 | 0.090 |
Why?
|
| Ketones | 1 | 2012 | 14 | 0.090 |
Why?
|
| Tosyl Compounds | 1 | 2012 | 13 | 0.090 |
Why?
|
| Titrimetry | 1 | 2012 | 15 | 0.090 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 20 | 0.090 |
Why?
|
| Immobilized Proteins | 1 | 2012 | 15 | 0.090 |
Why?
|
| Esters | 1 | 2012 | 31 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 826 | 0.090 |
Why?
|
| Sulfhydryl Compounds | 1 | 2012 | 68 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 86 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 1395 | 0.080 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 134 | 0.080 |
Why?
|
| Multiprotein Complexes | 2 | 2006 | 106 | 0.070 |
Why?
|
| Mutation | 1 | 2019 | 4272 | 0.070 |
Why?
|
| Genes, Developmental | 1 | 2007 | 6 | 0.060 |
Why?
|
| Adenylyl Imidodiphosphate | 1 | 2005 | 3 | 0.060 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2005 | 22 | 0.060 |
Why?
|
| DNA Topoisomerase IV | 1 | 2005 | 1 | 0.060 |
Why?
|
| Geobacillus stearothermophilus | 1 | 2005 | 10 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2005 | 61 | 0.060 |
Why?
|
| Borrelia burgdorferi | 1 | 2005 | 6 | 0.060 |
Why?
|
| RNA, Bacterial | 1 | 2006 | 101 | 0.060 |
Why?
|
| Vaccinia virus | 1 | 2005 | 20 | 0.060 |
Why?
|
| Static Electricity | 1 | 2005 | 94 | 0.060 |
Why?
|
| Electrons | 1 | 2005 | 51 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 1 | 2005 | 141 | 0.050 |
Why?
|
| Plasmids | 1 | 2005 | 273 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 319 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 337 | 0.050 |
Why?
|
| Neoplasms | 1 | 2019 | 3169 | 0.050 |
Why?
|
| Protein Domains | 1 | 2024 | 161 | 0.050 |
Why?
|
| Base Sequence | 2 | 2022 | 2220 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 284 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 2755 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 2 | 2016 | 100 | 0.040 |
Why?
|
| Introns | 1 | 2022 | 300 | 0.040 |
Why?
|
| Exons | 1 | 2022 | 450 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 2020 | 40 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2020 | 83 | 0.040 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 740 | 0.040 |
Why?
|
| Yeasts | 1 | 2019 | 50 | 0.040 |
Why?
|
| Catalysis | 2 | 2012 | 216 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 191 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 216 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2018 | 111 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 271 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 297 | 0.030 |
Why?
|
| Periodicity | 1 | 2017 | 113 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 457 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 1028 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 526 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1139 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 454 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1301 | 0.030 |
Why?
|
| Heart | 1 | 2017 | 522 | 0.030 |
Why?
|
| Single-Chain Antibodies | 1 | 2013 | 21 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1518 | 0.020 |
Why?
|
| Peptide Library | 1 | 2013 | 84 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1741 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2012 | 102 | 0.020 |
Why?
|
| Protons | 1 | 2012 | 102 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2012 | 307 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2495 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 295 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 238 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1922 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2010 | 260 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 438 | 0.020 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2007 | 3 | 0.020 |
Why?
|
| Transcription Factor TFIID | 1 | 2007 | 4 | 0.020 |
Why?
|
| 14-3-3 Proteins | 1 | 2007 | 10 | 0.020 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2007 | 28 | 0.020 |
Why?
|
| Amino Acids | 1 | 2007 | 249 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2006 | 163 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 304 | 0.010 |
Why?
|
| Adenosine Deaminase | 1 | 2006 | 26 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 379 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2007 | 439 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 409 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 342 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 988 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 306 | 0.010 |
Why?
|
| Male | 1 | 2020 | 44557 | 0.010 |
Why?
|